Navigation Links
New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma

he Company disclaims any intention or obligation to update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.


    Contacts:

    Jennifer Snyder (media)    Kyle Kuvalanka (investors)

    (617) 448-0281             (857) 498-0818

CONTACT: media, Jennifer Snyder, +1-617-448-0281, or investors, KyleKuvalanka, +1-857-498-0818, both of Millennium Pharmaceuticals, Inc.

Web site: http://www.millennium.com/

Company News On-Call: http://www.prnewswire.com/comp/114562.html /

Ticker Symbol: (NASDAQ-NMS:MLNM)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
5. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
6. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
7. Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated with Therapy Based on Ratiometric Dosing
8. Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
9. Pegasys Study Authors Conclude that Patients Successfully Treated for Hepatitis C Can be Considered Cured
10. Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent
11. Preterm Infants with Respiratory Distress Syndrome: Incidence Rates of Death when Treated with Surfactant Replacement Therapies

Post Your Comments:
(Date:11/6/2009)...,, DETROIT, Nov. 6 Ca... CPD ) has launched ketorolac tromethamine ophtha...m the US Food and Drug Administration (FDA) for Su... for generic Acular® ophthalmic solution on t...ength of ketorolac is therapeutically equivalent t...
(Date:11/6/2009)...,, WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -...an informal working group of mid-market and smalle...sed concerns about H.R. 3962, the "Affordable Heal...crats last Thursday. These smaller companies fear...s in H.R. 3962 will hinder their efforts to bring ...
(Date:11/6/2009)...,, HOPKINTON, Mass., Nov. 6 Fac...uired all of the assets of Archus Orthopedics. The...tion in product offerings, intellectual property a...ation. "This is a win for patients suffering from ...resident & CEO, Geoff Pardo. "This consolidat...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Facet Solutions Acquires Archus Orthopedics 2Thoratec Corporation and HeartWare International Inc Announce Termination of Proposed Transaction 53378 1Thoratec Corporation and HeartWare International Inc Announce Termination of Proposed Transaction 53378 2Thoratec Corporation and HeartWare International Inc Announce Termination of Proposed Transaction 53378 3CandleInTheWindow org Announces 241000 Scholarship Prize Winners 53375 1CandleInTheWindow org Announces 241000 Scholarship Prize Winners 53375 2Genes key to staph disease severity drug resistance found hitchhiking together 53372 1Genes key to staph disease severity drug resistance found hitchhiking together 53372 2
...Clinical Trial for the Treatment of Pediatric Eosi...RN, Pa., Jan. 13 Cephalon, Inc . (Nasdaq: CEPH...d biopharmaceutical company, today announced that ...ephalon with an option to purchase all outstanding... option agreement, Cephalon will pay Ception a $10...
... of disease progression versus placebo , , - Sand...rowth for a median of 14 months compared to six mo... LAR as first treatment after surgery in certain p... (NETs) , , EAST HANOVER, N.J., Jan. 13 Sandosta...for injection) demonstrated antitumor benefit in p...
Other Medicine Technology:Cephalon Signs Option Agreement to Acquire Ception Therapeutics 2Cephalon Signs Option Agreement to Acquire Ception Therapeutics 3Cephalon Signs Option Agreement to Acquire Ception Therapeutics 4New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors 2New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors 3New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors 4New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors 5New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors 6
(Date:11/9/2009)...Health Care Reform Bill, The Affordable Health Car...resentatives Saturday Night, and Is Expected to Be... of the Year with Absolute Confidence. ERISAclaim....tion Class Specifically for the Compliance with th... , Hanover Park, IL (PRWEB...
(Date:11/9/2009)...ing U.S. air ambulance company now the only worldw...ion and Department of Defense approval, , ..., 2009 -- AirMed International, the leading U.S. a...d full accreditation from the European Aero-Medica...any, based non-profit association of air medical p...
(Date:11/9/2009)...of the top cosmetic surgeons in Dallas and a &ldqu...chis, MD, FACS, has recently published his new, hi...n the Facial Plastic Surgery Clinics of North Amer...econstructive Surgeon, Dr. Bassichis’ innova...l filler treatments to achieve the most natural, r...
(Date:11/9/2009)...oung athletes are under increasing pressure to pla...University Health System study of 519 junior tenni...ases the risk of injury. Researchers who analyzed ...junior competition found that players who speciali...om tournaments for medical reasons, typically inju...
(Date:11/8/2009)...wswire-USNewswire/ -- Today, the nation Mayors com...g, the Affordable Health Care for America Act, a h...p in reforming America,s healthcare system. ,, ...ting in Providence (RI), mayors from across the na...principles of reducing the long-term growth of hea...
Breaking Medicine News(10 mins):Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 2Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 3Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 4Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 5Health News:AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation 2Health News:Dallas Facial Plastic Surgeon Publishes Cutting-Edge Novel Approach To Facelift Technique 2Health News:Young tennis players who play only 1 sport are more prone to injuries 2Health News:The Nation's Mayors Commend House Passage of Health Reform Bill 2
... ST. LOUIS, Nov. 3, 2008 America,s tweens and te... medications between 2002 and 2005, with girls bet...increase. One likely cause: Obesity, which is clo...ournal Pediatrics by researchers from the Saint ...
...bout 20 million voters with disabilities expected .... 3 Voters with disabilities,are expected to vote...he,American Association of People with Disabilitie...ots in the general election, about a 10 percent in...
...ENLO, Netherlands, Nov. 3 QIAGEN N.V.,(Nasdaq: Q...rter 2008,financial results call. The Webcast will...11, and will include remarks by Peer M. Schatz, Pr...s call, When: 9:30 a.m. EST on November 11, ...
...tate of the States in Developmental Disabilities a...ort as the U.S. confronts economic crisis, WASHIN...tate,s developmental disability services and analy...al,Disabilities study by David L. Braddock has kep...
...onference Call to Follow Release, DENVER, Nov. 3 ...the "Company") (OTC Bulletin Board: GLOB), an,inte... company, will report,its third quarter and nine m...ay., (Logo: http://www.newscom.com/cgi-bin/prnh/...
...EDFORD, Mass., Nov. 3 Insulet Corporation,(Nasdaq...ogy, and the,International Diabetes Federation (ID...tner of IDF,s World Diabetes Day (WDD) campaign. W...ase and,access to care., "Insulet,s mission is to...
Other Medicine News:Health News:Tweens and teens double use of diabetes drugs 2Health News:Tweens and teens double use of diabetes drugs 3Health News:Record Number of Voters with Disabilities Will Head to Polls 2Health News:Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Quarter 2008 Financial Results Call Set for November 11 2Health News:New Book Provides 30-Year Analysis of Financial and Programmatic Trends in Services and Funding for People with Intellectual and Developmental Disabilities in the United States 2Health News:Global Med Technologies(R) to Report Third Quarter and Nine-Month Financial Results on Thursday, November 13, 2008 2Health News:Global Med Technologies(R) to Report Third Quarter and Nine-Month Financial Results on Thursday, November 13, 2008 3Health News:Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign 2Health News:Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign 3
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: